BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 7 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 7 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 7 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 8 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 8 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 9 hours ago Atmus Welcomes Heath Sharp to Board of Directors 11 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 11 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 7 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 7 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 7 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 8 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 8 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 9 hours ago Atmus Welcomes Heath Sharp to Board of Directors 11 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 11 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago
ADVERTISEMENT
Analysis

Proto Labs Stock Surges on Strong Earnings

$PRLB February 6, 2026 2 min read

Proto Labs, Inc. (NYSE: PRLB) shares jumped about 8% during the trading day. This rise followed their earnings release. Investors showed optimism because the company reported record quarterly revenue and better profits. For context, the stock stayed within its 52-week range of $25 to $41. Recently, it has trended upward. Why? Expectations grew for production-manufacturing expansion and margin recovery. Meanwhile, no analyst rating changes or price-target updates appeared right after the news.

 

Q4 2025 Delivers Record Results

 

In Q4 2025, Proto Labs posted revenue of $136.5 million. That’s up 12.1% from last year—a new quarterly high. Strong production programs and CNC machining demand drove this growth. Additionally, net income reached $6.0 million, or $0.25 per diluted share. This compares to a net loss of $0.4 million, or $0.02 per share, a year earlier.

On a non-GAAP basis, net income hit $10.7 million, or $0.44 per share. That’s an increase from $9.4 million, or $0.38 per share. Non-GAAP gross margin also improved to about 45%. It expanded by 140 basis points year over year.

ADVERTISEMENT

By service line, CNC machining led the way with 25% growth. Injection molding saw modest gains. However, 3D printing dipped slightly. For example, revenue per customer contact rose over 23%. This signals deeper engagement in production work.

 

Full-Year 2025 Highlights Strong Growth

 

For the full year 2025, revenue reached a record $533.1 million, up 6.4% year over year. Net income came in at $21.2 million, or $0.88 per diluted share. That’s better than $16.6 million, or $0.66 per share, in 2024.

Non-GAAP net income totaled $40.2 million, or $1.66 per share. Adjusted EBITDA was $78.1 million, with a 14.7% margin. Revenue broke down by channel as follows: Factory at $416.9 million (up 4.1% YoY), and Network at $116.2 million (up 15.7% YoY). Operating cash flow stood at $74.5 million. Cash and investments ended the year at $142.4 million.

ADVERTISEMENT

 

Key Trends in Margins and Operations

 

Profitability got a boost from scale benefits. A mix shift toward higher-value production work helped too. CNC machining continued as the fastest-growing area. Customer spending also intensified. Management noted that changes over the past year aim to speed up growth. They also target better long-term profits.

 

Overall Outlook Looks Positive

 

ADVERTISEMENT

Overall, Proto Labs ended 2025 on a high note. Record revenue, wider margins, and solid earnings marked the year. Production demand and network growth provided support. Plus, the company keeps a debt-free balance sheet and strong cash flow.

ADVERTISEMENT